The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.


Updates from The Motley Fool

Latest updates on Illumina from Fool.com.


Stock Performance

ILMN vs. S&P 500 | 2 Year Performance
View Interactive ILMN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Illumina.
Current Price: $135.01
Prev Close: $135.48
Open: $136.41
Bid: $132.22
Ask: $135.22
Day's Range: $133.58 - $138.90
52wk Range: $127.10 - $242.37
Volume: 1,168,125
Avg Vol 1,072,247
Market Cap: $19.77B
P/E (ttm): 48.73
EPS (ttm): $2.78
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Illumina.
CAPS Rating 5 out of 5
 
1032 Outperform
56 Underperform
CAPS All Stars
 
248 Outperform
13 Underperform

How do you think Illumina will perform against the market?



You pick for Illumina is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Jay Flatley, CEO

99% Approve

Based on 186 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Illumina.

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers